What Is a GLP-1 Medication?

GLP-1 medications have transformed the treatment of type 2 diabetes and obesity over the past decade. From diabetes management to significant weight loss, these drugs address a fundamental biological problem: how your body controls appetite and blood sugar. Understanding how GLP-1 works is the first step to making an informed decision about whether it might be right for you.

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone produced in your gut. Your body releases GLP-1 when you eat, and it plays two critical roles: it tells your pancreas to release insulin (which lowers blood sugar), and it signals to your brain that you are full. This is how your body normally controls appetite and prevents overeating.

However, in people with type 2 diabetes or obesity, the natural GLP-1 system often does not work efficiently. The hormone is broken down too quickly, or the brain does not respond as strongly to the signal. The result is that blood sugar remains too high, and appetite remains unchecked.

How GLP-1 Medications Work

GLP-1 medications are designed to mimic the natural hormone. They are longer-acting than natural GLP-1, which means they stay in your bloodstream much longer. This allows them to provide a sustained effect throughout the week (for weekly injections like Mounjaro and Wegovy).

When you take a GLP-1 medication, three things happen in your body:

• Your pancreas releases more insulin in response to meals, lowering blood sugar naturally
• Your brain receives a stronger "fullness" signal, reducing appetite and food cravings
• Your stomach empties more slowly, keeping you feeling satisfied for longer

The result is that you eat less, feel fuller sooner, and experience fewer cravings. This is not about willpower or restriction—it is a biological change that makes eating less feel natural.

Why Diets Fail (And Why GLP-1 Works)

Most diets fail because they work against your biology. When you restrict calories, your body fights back by increasing hunger hormones and decreasing satiety signals. Your brain essentially becomes obsessed with food. This is not a character flaw; it is biology.

GLP-1 medications work differently. They work with your biology, not against it. By addressing the underlying hormonal imbalance, they reduce appetite without fighting your body's natural systems. The weight loss happens because you naturally want to eat less, not because you are forcing yourself to.

From Diabetes to Weight Loss

GLP-1 medications were first developed for type 2 diabetes. Drugs like Victoza and Bydureon became standard diabetes treatments because they lowered blood sugar effectively. Then, something remarkable happened: patients reported significant weight loss. Clinical trials confirmed that these medications caused weight loss even in people without diabetes.

This led to the development of higher-dose formulations specifically for weight loss. Wegovy (semaglutide) and Mounjaro (tirzepatide) are marketed for weight loss because they use doses designed to maximise appetite reduction and weight loss. Ozempic (another semaglutide product) is used for diabetes at lower doses.

Safety and MHRA Approval

GLP-1 medications have been studied extensively. Tens of thousands of people have used these drugs, and they have been approved by the MHRA (Medicines and Healthcare products Regulatory Agency) in the UK. Clinical trials show that they cause weight loss of 10-22% of body weight in most people, and they lower the risk of heart attack and stroke in people with type 2 diabetes.

Like all medications, GLP-1 drugs do have side effects. The most common are nausea, vomiting, and diarrhoea, especially when you first start. These usually improve after a few weeks. More serious side effects are rare but can include pancreatitis or thyroid issues in people with a personal or family history of thyroid cancer.

The Current UK Options

In the UK, two main GLP-1 medications are available for weight loss: Mounjaro (tirzepatide) and Wegovy (semaglutide). Both are injectable, taken once a week. Mounjaro acts on two hormone systems (GLP-1 and GIP), while Wegovy acts on GLP-1 alone. Both are effective, but they work slightly differently and may suit different people.

There are also older-generation GLP-1 medications, and other weight loss drugs outside the GLP-1 class. Your prescribing pharmacist will help you understand which option might be most suitable based on your health, weight loss goals, and medical history.

What to Expect

If you start a GLP-1 medication, you can expect to notice appetite reduction within days or weeks. Most people experience less interest in food, fewer cravings, and feeling fuller sooner. Weight loss typically begins within the first month and continues steadily over several months. Many people lose 10-15% of their body weight in the first year.

The medication is not a quick fix. You still need to eat healthily and move your body regularly. But because the medication addresses the biological drivers of hunger, it makes it much easier to do these things naturally.